Francesca Ceci
Norwalk, CTNPI 1225666431
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.2%), education and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 27.5% of the total. Reporting peaked in 2023 at $8,144 and has fallen 55.7% since, to $3,611 in 2025.
Across 508 payments — averaging $34.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$5K
- Dermavant Sciences, Inc.$3K
- Arcutis Biotherapeutics, Inc.$2K
- AbbVie$1K
- Sanofi$1K
- LEO Pharma Inc.$779
- plus $5K from 19 others
What the payments were for
- Consulting fees$3,32519%
- Speaking & faculty fees$901%
- Food & beverage$9,60854%
- Education$4,71027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 21 | $4,871 |
| Dermavant Sciences, Inc. | 18 | $3,095 |
| Arcutis Biotherapeutics, Inc. | 27 | $1,618 |
| AbbVie | 62 | $1,097 |
| Sanofi | 24 | $1,061 |
| LEO Pharma Inc. | 36 | $779 |
| Regeneron Healthcare Solutions, Inc. | 30 | $679 |
| Galderma Laboratories, L.p. | 25 | $663 |
| Incyte Corporation | 59 | $587 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 50 | $584 |
| Amgen | 20 | $468 |
| UCB, Inc. | 35 | $430 |
| Journey Medical Corporation | 30 | $366 |
| Johnson & Johnson | 21 | $284 |
| E.r. Squibb & Sons, L.L.C. | 4 | $208 |
| Janssen Scientific Affairs, LLC | 2 | $183 |
| Novartis | 8 | $171 |
| EPI Health, LLC | 5 | $141 |
| Lilly USA, LLC | 6 | $114 |
| Mayne Pharma Commercial LLC | 16 | $107 |
| Pfizer | 4 | $84 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Botanix SB Inc | 2 | $34 |
| Almirall LLC | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.